United States direct-to-consumer sales reached a record of more than $92,000 in a single day on October 11, 2026. Sales over the past 30 days totaled $902,000, while average daily sales over the past 10 days exceeded $60,000, double the 30-day average.
The figures cover sales through the Company's own branded online stores in the United States, including the 18 Series nutraceuticals, the NOOR brand and skincare products, sold both as individual purchases and through subscriptions.
Over the trailing 30 days, sales totaled $902,000, or approximately $30,000 per day. As brand awareness has continued to build, supported by targeted marketing, the pace has accelerated: average daily sales over the past 10 days have doubled to more than $60,000. Sustained over a full year, that rate would correspond to approximately $21.9 million in annualized sales. On October 11, 2026, daily sales reached a new high of more than $92,000.
As previously reported, the Company has projected annual revenue of over $23 million for its United States products within the next 12 to 18 months. The current 10-day pace already approaches that level.
A Direct Relationship with the Consumer
The Company believes that selling directly to consumers carries attractive margins and provides a direct relationship with the end customer, together with visibility over purchasing behavior that can inform product development and marketing across the wider portfolio. The channel also gives the Company greater control over pricing, presentation and the customer experience.
The United States has been the starting point for this model. Cosmos Health is evaluating opportunities to extend it over time, both to additional brands within its portfolio and to further markets.
At the current pace, we are already approaching the over $23 million annual target we set for the United States, and we intend to keep building on this momentum.